Drug Trial Radar · NCT07663838
A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV)
Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
42
Planned (sponsor's estimate)
Start
Aug 15, 2026
Primary completion
Jan 5, 2027
Study completion May 5, 2027
Sponsor
- Lead sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A randomized, multicenter, open-label, active-controlled Phase Ib study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of multiple intravaginal doses of GenSci142 in patients with bacterial vaginosis (BV).
Conditions
- Randomized
- Open-label
- Safety
- Tolerability
- Pharmacokinetics
- Bacterial Vaginosis
Interventions
GenSci142 capsuleDrug
Vaginal administration
clindamycin phosphate vaginal creamDrug
Clindamycin ointment, 5 grams, once daily for 7 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and severity of treatment-emergent adverse eventsTime frame: From the first dose to Day 30
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, China · Recruiting
The first Affiliated hospital of Henan Medical University
Xinxiang, Henan, China · Recruiting
Nanjing Maternity and Child Health Care Hospital
Nanjing, Jiangsu, China · Recruiting
Jiangxi Provincial Women and Children's Medical Center
Nanchang, Jiangxi, China · Recruiting
The First Hospital of Jilin University
Changchun, Jilin, China · Recruiting
Shandong Provincial Hospital
Jinan, Shandong, China · Recruiting
The Second Hospital of Shanxi Medical University
Taiyuan, Shanxi, China · Recruiting
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China · Recruiting
Affiliated Hangzhou First People's hospital
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.